Bureau Veritas enhances its Buildings & Infrastructure solutions through Buildings & Information Modeling digital enablement by acquiring IDP Group
Bureau Veritas, a global leader in Testing, Inspection, and Certification services, today announced the acquisition of IDP Group, a leading independent provider of BIM (Building Information Modeling), Project Management Assistance and Digital Twin services for the public and private sector, with strong positioning in decarbonization and other high-value verticals. This acquisition is aligned with Bureau Veritas LEAP | 28 strategy to expand leadership in B&I, while investing in strategic and promising digital portfolio assets to meet sustainability challenges.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241006677226/en/
Hinda Gharbi, CEO Bureau Veritas (Photo: Business Wire)
Bureau Veritas contributes to safer, sustainable and resilient buildings and infrastructures, delivering dedicated solutions from feasibility studies to construction and asset operations.
Its global reach and comprehensive assets service portfolio empower clients across the entire construction and value chain. This acquisition will expand Bureau Veritas’ B&I capabilities by enhancing its global end-to-end Buildings & Infrastructure services’ operational capabilities, leveraging innovative BIM expertise, consulting and Digital Twin asset digitalization.
The IDP Group provides its customers with advanced and integrated engineering services and multi-sector technical services for energy and electrification, industry, environment, Buildings & Infrastructure, data centers and telecommunications. Since 1998, the IDP Group has consistently invested in R&D, focusing on Digital Twin technology, decarbonization, and hydrogen initiatives. It delivered revenues of €30.2 million in 2023 and is headquartered in the Barcelona region. Capitalizing on c. 500 highly skilled experts, IDP Group will become a Bureau Veritas Global Technical Center for BIM, project management assistance and Digital Twin services allowing its expertise to scale up worldwide.
“Building on our recent portfolio high grading announced earlier today, we continue our inorganic growth strategy with the acquisition of IDP Group. This marks an important milestone for Bureau Veritas in delivering its LEAP | 28 strategy, expanding our digital services and competences as well as our innovation skills and strengthening our leading position in the B&I market,”said Hinda Gharbi, Chief Executive Officer of Bureau Veritas.“IDP Group has provided tangible value to a wide range of clients across various sectors in Spain during the past 26 years, supported by a seasoned management team. Joining forces with Bureau Veritas will help to further scale the company's capabilities internationally, benefitting our clients globally. I warmly welcome all our new colleagues from IDP Group.”
“The recent collaboration between Bureau Veritas’s and IDP’s teams allowed us to confirm the complementary technical capabilities of Bureau Veritas with our own,” added Enric Blasco, CEO of IDP Group. “This strategic union will not only enhance our service offering to our clients, but also consolidate our position as a global reference in these areas. We at IDP Group are proud and honored to be granted the responsibility of becoming a Bureau Veritas global technical center for BIM, and completing Project management assistance and digital services offerings, while benefiting from professional opportunities and career development for our employees on the scale of an international Group.”
***
About Bureau Veritas
Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress.
With a vision to be the preferred partner for its customers’ excellence and sustainability, the company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 83,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.
Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40 ESG, CAC Next 20, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com, and follow us on LinkedIn.
About IDP Group
IDP is the leading specialist in the provision of engineering services using BIM technology and methodology, with extensive national and international experience in the energy, industrial, logistics, environmental and data centre sectors. Its business model is based on innovation, which has allowed it to apply BIM to the entire life cycle of the asset (design, construction and maintenance), taking advantage of all its benefits in terms of improving design quality and reducing costs and execution times. The company has also developed differential capabilities in Digitalisation to improve the performance of assets through the development of Digital Twins, from construction to operation and maintenance. The company has a nationwide presence with 10 offices and a highly qualified team of 550 employees.
For more information, visit www.idp.es, and follow us on Linkedin.
Our information is certified with blockchain technology.
Check that this press release is genuine at www.wiztrust.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241006677226/en/
Contacts
ANALYST/INVESTOR CONTACTS
Laurent Brunelle
+33 (0)1 55 24 76 09
laurent.brunelle@bureauveritas.com
Colin Verbrugghe
+33 (0)1 55 24 77 80
colin.verbrugghe@bureauveritas.com
Karine Ansart
+33 (0)1 55 24 76 19
karine.ansart@bureauveritas.com
MEDIA CONTACTS
Anette Rey
+33 (0)6 69 79 84 88
anette.rey@bureauveritas.com
Martin Bovo
+33 (0) 6 14 46 79 94
martin.bovo@bureauveritas.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Microba Announces Landmark GI Study Results From Over 4,600 Patients15.5.2025 05:12:00 EEST | Press release
Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a precision microbiome company, today announces preliminary results from the analysis of over 4,600 MetaXplore™ GI Plus test results, a comprehensive test for the assessment and management of lower gastrointestinal disorders, spanning symptoms including chronic pain, bloating, constipation, or diarrhea. This study demonstrates that MetaXplore can support clinicians to identify and address underlying gut issues that often go undetected by conventional testing. In over 70% of cases, the test revealed findings, such as abnormalities in gut bacteria, signs of infection, markers of inflammation or insufficiency that could inform targeted treatment strategies. Further, two-thirds of MetaXplore patients in a separate study of follow up survey results reported improvement of symptoms after their care was guided by the test results. This press release features multimedia. View the full release here: https://www.businesswire.
Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan15.5.2025 05:00:00 EEST | Press release
Bloomstreet Inc. (Headquarters: Chuo-ku, Tokyo; President & CEO: Junichi Takayama; hereinafter “Bloomstreet”), a company that supports overseas enterprises entering the Japanese market, is pleased to announce a strategic partnership agreement with Google Israel Ltd. (Headquarters: Tel Aviv District; Country Manager: Barak Regev; hereinafter “Google Israel”). This partnership aims to support Israeli companies that operate globally with Google Ads and are seeking to expand into the Japanese market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514387485/en/ How do Bloomstreet and Google Israel collaborate? The partnership between Bloomstreet and Google Israel is designed to support Israeli companies seeking to expand into the Japanese market by optimizing their website UI/UX, thereby enhancing the effectiveness of their Google Ads campaigns. Background of the Partnership Known as a "Start-up Nation," Israel is home to many
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience15.5.2025 04:11:00 EEST | Press release
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced that using open source codes integrated in the company’s broader propriety drug discovery platform, ALEMBIC™, helped to identify senescent neurons in a new study that found senescent neurons drive chronic pain with injury and age.1 Senescent cells, often called “zombie” cells, arise as the results of cellular stress and damage. These senescent cells do not die but undergo cellular changes, including secreting pro-inflammatory factors, thereby potentially contributing to inflammatory responses within the body.1 The study, led by Stanford University scientists, Vivianne Tawfik, MD, PhD, and Lauren Donovan, PhD, and co-authored by Rubedo team members, including Chief Scientific Officer Marco Quarta, PhD, and Chief Technology Officer Alex Laslavic, was published in the May 14th edition of Nat
The New England Journal of Medicine Publishes Data from Phase 2b Trial of Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) in People with Narcolepsy Type 115.5.2025 00:03:00 EEST | Press release
Takeda (TSE: 4502/NYSE:TAK) today announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton (TAK-861) in people with narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to restore orexin signaling to address the underlying orexin deficiency that causes NT1. Results demonstrated significant improvement in objective and subjective measures of excessive daytime sleepiness (EDS), reductions in cataplexy events and clinically meaningful improvements in disease severity and quality of life across all doses tested compared to placebo through eight weeks of treatment. NT1 is a severe, chronic neurological condition caused by a significant loss of orexin-producing neurons, resulting in low levels of orexin leading to EDS, cataplexy (sudden loss of muscle tone), cognitive symptoms, disrupted nighttime sleep, hallucinations that occur as one falls asleep or wakes up and sleep paralysis.T
BeiGene Showcases Strength of Hematology Portfolio at EHA 2025 with New Data Highlighting BRUKINSA’s Leadership and Next-Generation Innovation14.5.2025 23:05:00 EEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share data across a range of hematologic malignancies at the European Hematology Association (EHA) Congress in Milan, Italy, June 12–15. BeiGene has 31 abstracts accepted at EHA 2025, with four selected for oral presentations, featuring data from its best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib) and its investigational pipeline assets – a next-generation BCL2 inhibitor, sonrotoclax, and BTK protein degrader, BGB-16673. These data reflect BeiGene’s vision to redefine standards of care in hematology through next-generation science and patient-focused innovation. “With three cornerstone hematology assets – BRUKINSA, sonrotoclax and BGB-16673 – we are advancing a potentially best-in-class portfolio in B-cell malignancies,” said Lai Wang, Ph.D. Global Head of R&D. “At EHA 2025, we’ll share 31 accepted ab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom